Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2006 Sep;90(9):1207-8.
doi: 10.1136/bjo.2006.093732.

Acute retinal pigment epithelial tear following intravitreal bevacizumab (Avastin) injection for occult choroidal neovascularisation secondary to age related macular degeneration

C H Meyer, S Mennel, J C Schmidt, P Kroll
Case Reports

Acute retinal pigment epithelial tear following intravitreal bevacizumab (Avastin) injection for occult choroidal neovascularisation secondary to age related macular degeneration

C H Meyer et al. Br J Ophthalmol. 2006 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Proprietary interest: none.

References

    1. Gelisken F, Inhoffen W, Partsch M.et al Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularization. Am J Ophthalmol 2001131518–520. - PubMed
    1. Rosenfeld P J, Moshfeghi A A, Puliafito C A. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age‐related macular degeneration. Ophthalmic Surg Lasers Imaging 200536331–335. - PubMed
    1. Meyer C H, Toth C A. Retinal pigment epithelial tear with vitreomacular attachment: a novel pathogenic feature. Graefes Arch Clin Exp Ophthalmol 2001239325–333. - PubMed
    1. Hesse L. Tissue‐type plasminogen activator. An enzyme with multiple uses in ophthalmology. Ophthalmologe 199794366–371. - PubMed
    1. Gragoudas E S, Adamis A P, Cunningham E T., Jret al VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age‐related macular degeneration. N Engl J Med 20043512805–2816. - PubMed

MeSH terms